Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline

Protect the integrity of USPSTF, patient and provider groups urge in letter to Kennedy

In a letter, sixty organizations representing cancer patients and providers are urging HHS Secretary Robert F. Kennedy Jr. to maintain the integrity of the U.S. Preventive Task Force.

May 29, 2026

Vol.52 No.21

By Claire Marie Porter

Clinical Roundup

USC comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions

A head-to-head comparison of five leading treatments for anaplastic lymphoma kinase-positive non-small cell lung cancer could help oncologists fine-tune first-line TKI selection beyond what’s been seen in clinical trials alone, according to a study conducted by a team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the USC Shaeffer Center for Health Policy & Economics have conducted.

May 22, 2026

Vol.52 No.20

Clinical Roundup

Despite breakthroughs, many go without treatment for metastatic lung cancer, MUSC study finds

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan and quality of life for many patients.

May 15, 2026

Vol.52 No.19

In Brief

American Cancer Society names four members to Board of Directors

The American Cancer Society has appointed four members to its Board of Directors. Together, they will help guide how the American Cancer Society sets priorities, stewards resources, and measures progress, ensuring the organization remains focused on delivering meaningful impact for cancer patients and their families.

May 08, 2026

Vol.52 No.18

Podcast

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

The Cancer Letter’s coverage of HHS-led overhauls of foundational scientific institutions continued last week with two unrelated stories pointing to continued disarray amongst public health leadership.

May 06, 2026

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

Health and Human Services Secretary Robert F. Kennedy Jr. is moving to overhaul the U.S. Preventive Services Task Force, a highly influential panel that determines which preventive services insurers must cover and guides routine medical care for millions of Americans.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline

YOU MAY BE INTERESTED IN

Protect the integrity of USPSTF, patient and provider groups urge in letter to Kennedy

USC comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions

Despite breakthroughs, many go without treatment for metastatic lung cancer, MUSC study finds

American Cancer Society names four members to Board of Directors

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

Renew today!

Subscriber content

Never miss an issue!

Login

Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline

YOU MAY BE INTERESTED IN

Protect the integrity of USPSTF, patient and provider groups urge in letter to Kennedy

USC comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions

Despite breakthroughs, many go without treatment for metastatic lung cancer, MUSC study finds

American Cancer Society names four members to Board of Directors

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panelRansohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

Never miss an issue!

Login

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”